Skip to main content
. 2016 Aug 24;12(5):1088–1096. doi: 10.5114/aoms.2016.61915

Figure 3.

Figure 3

Forest plot of meta-analysis for vedolizumab vs. placebo of clinical remission: A – in the general population (ITT analysis) at week 6, B – in the subpopulation of patients who reported no response and/or poor tolerance of the prior treatment with TNF antagonists at week 6, and C – in the TNF antagonist-naive subgroup at week 6